1 - 10 of 23 articles
Key PointsQuestionDoes the ABCD-10 score (age, bicarbonate, cancer, dialysis, 10% body surface area), a new risk prediction model for in-hospital mortality in epidermal necrolysis, show better performance than the Score of Toxic Epidermal Necrolysis (SCORTEN)?
FindingsIn this cohort study of 196...
Key PointsQuestionWhat are the trends in age-standardized incidence rates of cutaneous squamous cell carcinoma (cSCC) from 1989 to 2017 and the estimated trends up to 2027 in the Netherlands and how are these rates associated with the inclusion of multiple cSCCs per patient?
This cohort study uses registry-based data of US organ transplant recipients to assess the incidence of sebaceous carcinoma and patient survival among solid organ transplant recipients from 1987 through 2017.
Key PointsQuestionWhat is the efficacy and safety of VP-102, a drug-device combination containing cantharidin, 0.7% (w/v), in individuals aged 2 years or older with molluscum contagiosum compared with vehicle?
FindingsIn 2 identical phase 3 trials (Cantharidin Application in Molluscum Patients...
Key PointsQuestionWhat are the incidence rate and risk factors for keratoacanthoma?
FindingsIn this cohort study of 40 438 residents of Queensland, Australia, the person-based incidence rate for keratoacanthoma was 409 individuals per 100 000 person-years. Older age, male sex, UV radiation...
Key PointsQuestionWhat is the efficacy and safety of 4 mg and 2 mg of baricitinib in combination with background topical corticosteroid (TCS) therapy in adults with moderate to severe atopic dermatitis (AD)?
FindingsIn this randomized clinical trial of 329 adults with moderate to severe AD, at...
Key PointsQuestionWhat are the patient-reported outcomes of risankizumab treatment for moderate to severe chronic plaque psoriasis in UltIMMa-1 and UltIMMa-2?
FindingsData from 997 patients who were randomized 3:1:1 to risankizumab, ustekinumab, and placebo in 2 replicate 52-week clinical trials...
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.